FDA research to help speed development of Zika virus vaccines and therapeutics

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA research to help speed development of Zika virus vaccines and therapeutics

View as a webpage

News Release

For Immediate Release:

Nov. 17, 2016

Media Inquiries:

Tara Goodin, 240-402-3157, tara.goodin@xxxxxxxxxxx � Lauren Smith Dyer, 301-348-1888, lauren.smith2@xxxxxxxxxxx

Consumer Inquiries:

888-INFO-FDA

FDA research to help speed development of Zika virus vaccines and therapeutics

Neonatal mouse model provides a new platform for Zika virus research

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.

Read more.

###

---

Subscriber Services:
Manage Preferences��|��Unsubscribe��|��Help with this service

Stay Connected:

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) � 10903 New Hampshire Ave � Silver Spring, MD 20993 � 1-888-INFO-FDA (1-888-463-6332)